Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/ pharmacodynamics theory

Japanese Journal of Antibiotics

Volumn 57, Issue 6, 2004, Pages 465-474

  Nakamura, Tatsuya ^a   Takahashi, Hakuo ^a  

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFACLOR; CEFCAPENE; CEFDINIR; CEFDITOREN; CEFPODOXIME; CEFROXADINE; CEFTERAM; CEPHEM; PENICILLIN BINDING PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; ERADICATION THERAPY; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTERIA; BETA-LACTAMASES; CEPHALOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; JAPAN; MODELS, BIOLOGICAL; MUTATION; PENICILLIN-BINDING PROTEINS; TIME FACTORS;

EID: 12544249251     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. BROWN, S. D. & M. J. RYBAK: Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. J. Antimicrob. Chemother. 54: 7-15, 2004
2. YAGI, T.; H. KUROKAWA, N. SHIBATA, et al.: A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol, Lett. 184: 53-56, 2000
3. MORIKAWA, Y.; M. KITAZATO, C. KATSUKAWA, et al.: Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan. J. Infect. Chemother. 9: 131-133, 2003
4. UBUKATA, K.; N. CHIBA, K. HASEOAWA. et al.: Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob. Agents Chemother. 48: 1488-1494, 2004
5. CRAIG, W. A.: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26: 1-12, 1998
6. CRAIG, W. A.: Does the dose matter? Clin. Infect. Dis. 33: 233-237, 2001
7. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; 12th information supplement. NCCLS document M100-S10, 2002, National Committee for Clinical Laboratory Standards, Wayne, Pa, USA
8. (Japanese characters): Cefroxadine (CGP-9000) (Japanese characters). Chemotherapy 28: 176-183, 1980
9. (Japanese characters): Cefdinir (Japanese characters). Chemotherapy 37: 246-256, 1989
10. (Japanese characters): CS-807 (Japanese characters). Chemotherapy 36: 434-441, 1988
11. TREMBLAY, D.; A. DUPRONT, C. HO, et al: Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses. J. Antimicrob. Chemother. 26: 21-28, 1990
12. (Japanese characters): Cefaclor (Japanese characters). Chemotherapy 27: 158-173, 1979
13. (Japanese characters), ME1207 (Japanese characters). Chemotherapy 40: 105-119, 1992
14. (Japanese characters): Cefixime (CFIX) (Japanese characters). Chemotherapy 33: 190-203, 1985
15. (Japanese characters): T-2588 (Japanese characters). Chemotherapy 34: 134-143, 1986
16. (Japanese characters): T-2588 (Japanese characters). Jpn. J. Antibiot. 42: 55-76, 1986
17. GHAFFAR, F.; L. S. MUNIZ, K. Katz, et al.: Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin. Infect. Dis. 34: 1301-1309, 2002
18. KARL, D.: The mutant selection window and antimicrobial resistance. J. Antimicrob. Chemother. 52: 11-17, 2002
19. (Japanese characters) pharmacodynamics parameter (Japanese characters), MIC (Japanese characters) time above the MIC (Japanese characters). Jpn. J. Antibiotics 56: 697-704, 2003